CSS
OLMA icon

Cubist Systematic Strategies’s Olema Pharmaceuticals OLMA Stock Holding History

Cubist Systematic Strategies’s Portfolio OLMA Stock Details OLMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-93,669
Closed -$352K – 3364
2025
Q1 		$352K Buy
93,669
+67,682
+260% +$340K ﹤0.01% 2317
2024
Q4 		$152K Buy
+25,987
New +$260K ﹤0.01% 2638
2024
Q3 		– Sell
-13,416
Closed -$145K – 3352
2024
Q2 		$145K Buy
+13,416
New +$145K ﹤0.01% 2571
2023
Q2 		– Sell
-15,161
Closed -$52.6K – 4074
2023
Q1 		$52.6K Buy
15,161
+1,041
+7% +$4.25K ﹤0.01% 3557
2022
Q4 		$34.6K Sell
14,120
-23,194
-62% -$67.6K ﹤0.01% 3947
2022
Q3 		$103K Sell
37,314
-31,421
-46% -$133K ﹤0.01% 4010
2022
Q2 		$280K Sell
68,735
-25,555
-27% -$81K ﹤0.01% 3483
2022
Q1 		$402K Buy
94,290
+9,092
+11% +$50.1K ﹤0.01% 2670
2021
Q4 		$797K Buy
85,198
+43,366
+104% +$899K 0.01% 2099
2021
Q3 		$1.15M Buy
41,832
+39,682
+1,846% +$1.07M 0.01% 1411
2021
Q2 		$60K Buy
+2,150
New +$61.2K ﹤0.01% 2772

Other funds holding OLMA

BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Cubist Systematic Strategies's OLMA Position: Q2 2025 in Review

Cubist Systematic Strategies sold out of Olema Pharmaceuticals (OLMA) in Q2 2025, closing a stake of 93,669 shares — an estimated $352K sold.

Cubist Systematic Strategies first reported a position in OLMA in Q2 2021 and held it in 11 quarters. The position peaked at $1.15M in Q3 2021. 122 funds tracked by Wall St. Rank hold OLMA as of Q2 2025.

  • Cubist Systematic Strategies reported no remaining Olema Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
  • Cubist Systematic Strategies sold 93,669 Olema Pharmaceuticals shares in Q2 2025, an estimated $352K.
  • Cubist Systematic Strategies first reported a position in Olema Pharmaceuticals in Q2 2021 and held it in 11 quarters.
  • Cubist Systematic Strategies's Olema Pharmaceuticals position peaked at $1.15M in Q3 2021.
  • 122 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q2 2025.

Based on Cubist Systematic Strategies's 13F filing for Q2 2025, filed 14 Aug 2025.